15-31070149-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001252024.2(TRPM1):c.161G>A(p.Ser54Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,613,992 control chromosomes in the GnomAD database, including 527,388 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001252024.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM1 | NM_001252024.2 | c.161G>A | p.Ser54Asn | missense_variant | 4/28 | ENST00000256552.11 | NP_001238953.1 | |
TRPM1 | NM_001252020.2 | c.212G>A | p.Ser71Asn | missense_variant | 3/27 | NP_001238949.1 | ||
TRPM1 | NM_002420.6 | c.95G>A | p.Ser32Asn | missense_variant | 3/27 | NP_002411.3 | ||
TRPM1 | NM_001252030.2 | c.95G>A | p.Ser32Asn | missense_variant | 3/3 | NP_001238959.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPM1 | ENST00000256552.11 | c.161G>A | p.Ser54Asn | missense_variant | 4/28 | 1 | NM_001252024.2 | ENSP00000256552 | P4 |
Frequencies
GnomAD3 genomes AF: 0.797 AC: 121200AN: 151996Hom.: 48525 Cov.: 32
GnomAD3 exomes AF: 0.806 AC: 201110AN: 249460Hom.: 81955 AF XY: 0.795 AC XY: 107536AN XY: 135342
GnomAD4 exome AF: 0.808 AC: 1180560AN: 1461878Hom.: 478819 Cov.: 83 AF XY: 0.802 AC XY: 583244AN XY: 727242
GnomAD4 genome AF: 0.797 AC: 121299AN: 152114Hom.: 48569 Cov.: 32 AF XY: 0.794 AC XY: 59069AN XY: 74350
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Congenital stationary night blindness 1C Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 25, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at